Funding

Current Funding

1. Clinical Predictors of Response to IV Ketamine in Treament-Resistant Depression: A Randomized Double-Blinded, Midazolam-Controlled Pilot Study
   • QEI.I. Foundation
   • 2023-2024
2. Electrophysiological Predictors of Ketamine Response
   • Nova Scotia Health Research & Innovation (Innovation Catalyst Fund)
   • 2023-2024
3. Computational Modelling of Memory Impairment Mechanisms in Bipolar Disorder
   • Research Nova Scotia New Health Investigator Grant (RNS-NHIG-2021-1931)
   • 2022-2024